Breaking News, Promotions & Moves

Aprecia Appoints Regulatory Affairs SVP

Kathi Rinesmith to oversee strategic regulatory affairs for the company's expanding pipeline of 3D-printed pharmaceuticals.

By: Contract Pharma

Contract Pharma Staff

Aprecia, the 3DP Pharmaceutical Company, has appointed Kathi Rinesmith, R.Ph., MS as senior vice president of regulatory affairs. Rinesmith will lead the company’s regulatory strategy, objectives, policies and programs pertaining to the development and marketing of drug products manufactured with Aprecia’s proprietary three-dimensional printing (3DP) technology platform, ZipDose Technology.   Rinesmith brings more than thirty years of experience related to the development and registr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters